Gamma delta T-lymphocytes in hepatitis C and chronic liver disease

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Rajoriya, N ^a   Fergusson, J ^a   Leithead, J A ^b   Klenerman, P ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Gamma delta T lymphocytes; T cells

Indexed keywords

EID: 84919444686     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00400     Document Type: Article

References (84)

1. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. 2007). Phenotypic and functional features of human Th17 cells". J Exp Med 204(8): 1849-61.
2. Agrati C, D'Offizi G, Narciso P, Abrignani S, Ippolito G, Colizzi V, et al. 2001). "Vδ1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons". Mol Med; 7(1):11-19
3. Agrati C, D'Offizi G, Narciso P, Selva C, Pucillo LP, Ippolito G, et al. (2001) "Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic Vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy." AIDS Res Hum Retroviruses 17(14):1357-63.
4. Agrati C, Alonzi T, de Santis R, Castilletti C, Abbate I, Capobianchi MR, et al. (2006). "Activation of Vγ9Vδ2 T-cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication". Int Immunol 18(1):11-18
5. Battistini L, Borsellino G, Sawicki G, Poccia F, Salvetti M, Ristori G, et al. 1997). Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol 159(8): 3723-30
6. Bade B, Boettcher HE, Lohrmann J, Hink-Schauer C, Bratke K, Jenne DE, et al. (2005). Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes. Int Immunol17(11): 1419-28
7. Billerbeck E, Kang YH, Walker L, Lockstone H, Grafmueller S, Fleming V, et al. (2010). "Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties". Proc Natl Acad Sci U S A 107(7):3006-11. doi: 10.1073/pnas.0914839107.
8. Bonneville M, O'Brien RL, Born WK. (2010) "Gammadelta T-cell effector functions: a blend of innate programming and acquired plasticity". Nat Rev Immunol 10(7):467-78. doi: 10.1038/nri2781.
9. Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintière C, Daniel P, et al (2008) "Vgamma9Vdelta2 T-cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas" Cancer Immunol Immunother 57(4):531-39
10. Boullier S, Dadaglio G, Lafeuillade A, Debord T, Gougeon ML. (1997). V delta 1 T cells expanded in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-alpha and IFN-gamma production but are not selected in lymph nodes. J Immunol 159(7): 3629-37
11. Brenner MB, McLean, J, Dialynas DP, Strominger JL, Smith JA, Owen FL, Seidman JG. et al (1986). Identification of a putative second T-cell receptor. Nature 322(6075): 145-9
12. Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, 2009). Characterization and immunotherapeutic potential of gamma delta T-cells in patients with glioblastoma. Neuro Oncol 11(4):357-67. doi: 10.1215/15228517-2008-111.
13. Caccamo N, La Mendola C, Orlando V, Meraviglia S, Todaro M, Stassi G, et al. (2011) "Differentiation, phenotype and function of interleukin-17 producing human V γ9Vδ2 T-cells". Blood 118:129-38. doi: 10.1182/blood-2011-01-331298
14. Chen M, Zhang D, Zhen W, Shi Q, Liu Y, Ling N, et al. (2008). Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection". J Infect Dis 198(11):1643-50. doi: 10.1086/593065.
15. Chien YH and Bonneville M (2006). Gamma delta T cell receptors. Cellular and molecular life sciences: Cell Mol Life Sci 63(18): 2089-94
16. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, et al. 2008). Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 205(8): 1903-1916. doi: 10.1084/jem.20080397
17. Das H, Sugita M, Brenner M B. (2004) Mechanisms of Vdelta1 gammadelta cell activation by microbial components. J. Immunol. 172(11):6578-86
18. Déchanet J, Merville P, Lim A, Retière C, Pitard V, Lafarge X, et al. (1999). Implication of gamma delta T cells in the human immune response to cytomegalovirus. J Clin Invest 103(10): 1437-49
19. De Paoli P, Basaglia G, Gennari D, Crovatto M, Modolo ML, Santini G. 1992). Phenotypic profile and functional characteristics of human gamma and delta T cells during acute toxoplasmosis. J Clin Microbiol 30(3): 729-31
20. Dusseaux M, Martin E, Serriari N, Péguillet I, Premel V, Louis D, et al. (2011). Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells". Blood;117(4):1250-9. doi: 10.1182/blood-2010-08-303339.
21. Eberl M, Jomaa H, Hayday AC (2004). Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells. Immunology 112(3): 364-368
22. Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. (2010) "A multifaceted imbalance of T-cells with regulatory function characterizes type 1 autoimmune hepatitis". Hepatology;52(3): 999-1007. doi: 10.1002/hep.23792.
23. Forrest EH, Morris AJ, Stewart S, Phillips M, Oo YH, Fisher NC, et al. (2007). "The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids". Gut. 56(12): 1743-1746
24. García VE, Sieling PA, Gong J, Barnes PF, Uyemura K, Tanaka Y, et al. (1997). Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol 159(3): 1328-35
25. Halstensen TS, Scott H, Brandtzaeg P. (1989). Intraepithelial T cells of the TcR gamma/delta+ CD8-and V delta 1/J delta 1+ phenotypes are increased in coeliac disease. Scand J Immunol 30(6): 665-72
26. Hayday AC (2009) "γδ T-cells and the lymphoid stress-surveillance response". Immunity 31(2);184-96. doi: 10.1016/j.immuni.2009.08.006.
27. Hoh A, Dewerth A, Vogt F, Wenz J, Baeuerle PA, Warmann SW, et al. (2013) The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture. Liver Int. 33(1):127-36.doi: 10.1111/liv.12011
28. Iiai T, Watanabe H, Suda T, Okamoto H, Abo T, Hatakeyama K. (2002). "CD161+ T (NT) cells exist predominantly in himan intestinal epithelium as well as in liver". Clin Exp Immunol;129(1):92-98
29. Kabelitz D, Bender A, Schondelmaier S, da Silva Lobo ML, Janssen O. (1990). Human cytotoxic lymphocytes. V. Frequency and specificity of gamma delta+ cytotoxic lymphocyte precursors activated by allogeneic or autologous stimulator cells. J Immunol 145(9): 2827-32
30. Kabelitz D, Glatzel A, Wesch D. (2000). "Antigen recognition by human gammadelta T lymphocytes". Int Arch Allergy Immunol 122(1):1-77
31. Kanayama K, Morise K, Nagura H. (1992) "Immunohistochemical study of T cell receptor gamma delta cells in chronic liver disease". Am J Gastroenterol 87:1018-22.
32. Kang YH, Seigel B, Bengsch B, Fleming VM, Billerbeck E, Simmons R, et al. (2012) "CD161(+)CD4(+) T-cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ". Front Immunol 20;3:346. doi: 10.3389/fimmu.2012.00346.
33. Kasper HU, Ligum D, Cucus J, Stippel DL, Dienes HP, Drebber U. (2009). Liver distribution of gammadelta-T-cells in patients with chronic hepatitis of different etiology. APMIS 117(11):779-785. doi: 10.1111/j.1600-0463.2009.02540.x.
34. Kenna T, Golden-Mason L, Norris S, Hegarty JE, O'Farrelly C, Docherty DG. (2004). "Distinct subpopulations of gamma delta T cells are present in normal and tumour bearing human liver. Clin Immunol" 113(1):56-63
35. Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, et al. (2009). Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 206(3): 525-34. doi: 10.1084/jem.20081712
36. Klenerman P, Thimme R. (2012). "T-cell responses in hepatitis C: the good, the bad and the unconventional". Gut 61(8):1226-34 doi: 10.1136/gutjnl-2011-300620.
37. Knight A, Madrigal AJ, Grace S, Sivakumaran J, Kottaridis P, Mackinnon S, et al. (2010). The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 116(12): 2164-2172 doi: 10.1182/blood-2010-01-255166.
38. Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, et al. (2007). Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transplant Immunol17(2): 94-7
39. Laggner U, Di Meglio P, Perera GK, Hundhausen C, Lacy KE, Ali N, et al. (2011). Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis. J Immunol 187(5): 2783-93.doi: 10.4049/jimmunol.1100804.
40. Lanier LL, Chang C, Phillips JH. (1994). Human NKR-P1A. A disulfide linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. Journal of immunology 153(6): 2417-28.
41. Lauer GM, Walker BD. (2001) "Hepatitis C virus infection". N Engl J Med; 345(1):41-52
42. Lucas C, Ingoure S (2009). "IPH1101, the first specific gamma-delta T-cell agonist, shows potent immuno-biological efficacy in low grade follicular lymphoma patients when combined with Rituximab: reults from a phase II Study". ASH Annual meeting;114:583
43. Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, et al. (2011) "Contribution of IL-17-producing gamma delta-T cells to the efficacy of anticancer chemotherapy". J Exp Med 208:491-501. doi: 10.1084/jem.20100269.
44. Mackay IR. (2007) "Contemporary liver immunology: Obstacles and Opportunities. Liver Immunology Principles and practice (Humania Press)"
45. Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ, et al (2010). CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Euro J Immunol 40(8): 2174-81 doi: 10.1002/eji.200940257.
46. Malan-Borel I, Racca A, Garcia MI, Bailat A, Quiroga F, Soutullo A, et al. (2003). Gammadelta T cells and interleukin-6 levels could provide information regarding the progression of human renal allograft. Scand J Immunol 58(1):99-105
47. Malone F, Carper K, Reyes J, Li W. (2009) Gamma delta T cells are involved in liver transplant tolerance. Transpl Proc 41(1): 233-35. doi: 10.1016/j.transproceed.2008.10.040.
48. Martin E, Treiner E, Duban L, Guerri L, Laude H, Toly C, et al. (2009) "Stepwise Development of MAIT Cells in Mouse and Human". PLoS Biol 7(3): e1000054. doi: 10.1371/journal.pbio.1000054.
49. Martínez-Llordella M, Puig-Pey I, Orlando G, Ramoni M, Tisone G, Rimola A, et al. (2007). Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transpl 7(2): 309-19
50. Mehal WZ, Azzaroli F, Crispe IN. "Immunology of the healthy liver: old questions and new insights". Gastroenterology. 2001;120:250-60.
51. Nakajima J, Murakawa T, Fukami T, Goto S, Kaneko T, Yoshida Y, et al (2010). "A phase 1 study of adoptive immunotherapy for recurrent non-small cell lung cancer patients with autologous gammadelta T cells". Eur J Cardiothorac Surg;37:1191-7. doi: 10.1016/j.ejcts.2009.11.051.
52. Ness-Schwickerath KJ, Jin C, Morita CT. (2010). Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. J Immunol 184(12): 7268-80. doi: 10.4049/jimmunol.1000600.
53. Northfield JW, Kasprowicz V, Lucas M, Kersting N, Bengsch B, Kim A, et al. (2008). CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 47(2): 396-406. doi: 10.1002/hep.22040.
54. Norris S, Doherty DG, Collins C, McEntee G, Traynor O, Hegarty JE, et al (1999). Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Human Immunol 60(1): 20-31.
55. Pár G, Rukavina D, Podack ER, Horányi M, Szekeres-Barthó J, Hegedüs G, et al. (2002). Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol 37(4): 514-522
56. Peng MY, Wang ZH, Yao CY, Jiang LN, Jin QL, Wang J, et al. (2008). "Interleukin 17-producing gamma delta T cells increased in patients with active pulmonarytuberculosis". Cell Mol Immunol 5(3):203-8.
57. Poggi A, Costa P, Zocchi MR, Moretta L. (1997). NKRP1A molecule is involved transendothelial migration of CD4+ human T lymphocytes. Immunol Lett 57(1-3): 121-123.
58. Poggi A, Costa P, Tomasello E, Moretta L. (1998). IL-12-induced up regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur J Immunol 28(5): 1611-16.
59. Poggi A, Zocchi MR, Carosio R, Ferrero E, Angelini DF, Galgani S, et al. (2002). Transendothelial migratory pathways of V delta 1+TCR gamma delta+ and V delta 2+TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients: involvement of phosphatidylinositol 3 kinase and calcium calmodulin-dependent kinase II. J Immunol 168(12): 6071-77.
60. Poggi A, Costa P, Tomasello E, Moretta L. (1998). IL-12-induced up regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur J Immunol 28(5): 1611-16.
61. Poggi A, Zocchi MR, Costa P, Ferrero E, Borsellino G, Placido R, et al. (1999). IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. Journal of immunology 162(7): 4349-54.
62. Poggi A, Costa P, Zocchi MR, Moretta L. (1997). Phenotypic and functional analysis of CD4+ NKRP1A+ human T lymphocytes. Direct evidence that the NKRP1A molecule is involved in transendothelial migration. Eur J Immunol 27(9): 2345-50
63. Puig-Pey I, Bohne F, Benítez C, López M, Martínez-Llordella M, Oppenheimer F, al. (2010). Characterization of γδ T cell subsets in organ transplantation. Transpl Int. 23(10):1045-55. doi: 10.1111/j.1432-2277.2010.01095.
64. Rosen DB, Cao W, Avery DT, Tangye SG, Liu YJ, Houchins JP, et al. (2008). Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol 180(10): 6508-17.
65. Saito H, Kranz DM, Tagaki Y, Hayday AC, Eisen HN, Tonegawa S. (1984) Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature 309(5971): 757-62
66. Schirmer L, Rothhammer V, Hemmer B, Korn T. (2013) Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis. JAMA Neurol. 70(3): 345-51
67. Skeen MJ, Ziegler HK. (1995) Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J. Immunol. 154(11): 5832-41
68. Spada FM, Grant EP, Peters PJ, Sugita M, Melián A, Leslie DS, et al. (2000). Self recognition of CD1 by gamma/delta T-cell: implications for innate iummunity". J Exp Med 191;937-48
69. Stinissen P, Vandevyver C, Medaer R, Vandegaer L, Nies J, Tuyls L, et al. 1995). Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. Journal of immunology 154(9): 4883-94.
70. Takahashi T, Dejbakhsh-Jones S, Strober S. (2006). Expression of CD161 NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176(1): 211-216
71. Triebel F and Hercend T (1989). Subpopulations of human peripheral T gamma delta lymphocytes. Immunology today 10(6): 186-8
72. Thomson EC, Fleming VM, Main J, Klenerman P, Weber J, Eliahoo J, et al. 2011). Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1 infected men. Gut 2011;60(6):837-45. doi: 10.1136/gut.2010.217166.
73. Tseng CT, Miskovsky E, Houghton M, Klimpel GR. (2001). Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 33(5): 1312-20.
74. Uldrich AP, Le Nours J, Pellicci DG, Gherardin NA, McPherson KG, Lim RT, et al. CD1d-lipid antigen recognition by the γδ TCR." Nat Immunol. 2013 Nov;14(11):1137-45. doi: 10.1038/ni.2713.
75. Ussher JE, Bilton M, Attwod E, Shadwell J, Richardson R, de Lara C, et al. (2014). CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur. J. Immunol. 44(1):195-203. doi: 10.1002/eji.201343509.
76. Vavassori S, Kumar A, Wan GS, Ramanjaneyulu GS, Cavallari M, El Daker S, et al. 2013) "Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells." Nat Immunol 14(9):908-16. doi: 10.1038/ni.2665.
77. Vermijlen D, Ellis P, Langford C, Klein A, Engel R, Willimann K, et al. 2007). "Distinct cytokine-driven responses of activated blood gammadelta T-cells: insights into unconventional T-cell pleitropy". J Immunol 178:4304-14
78. Viney J, MacDonald TT, Spencer J. (1990). Gamma/delta T cells in the gut epithelium. Gut 31(8): 841-44
79. Walker LJ, Kang YH, Smith MO, Tharmalingham H, Ramamurthy N, Fleming VM, et al. (2011). Human MAIT and CD8αα cells develop from a pool of type-17 pre-committed CD8+ T cells. Blood. 119(2):422-33. doi: 10.1182/blood-2011-05-353789
80. Wang L, Das H, Kamath A, Bukowski JF. (2001). Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products. Journal of immunology 167(11): 6195-201
81. Wencker M, Turchinovich G, Di Marco Barros R, Deban L, Jandke A, Cope A, et al. (2014). Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. Nature Immunol 15(1): 80-7. doi: 10.1038/ni.2773.
82. Wesch D, Glatzel A, Kabelitz D. (2001) "Differentiation of resting human peripheral blood γδ T-cells towards Th1-or Th2-phenotype". Cell Immunol 212:110-7
83. Wesch D, Peters C, Oberg HH, Pietschmann K, Kabelitz D. (2011). "Modulation of γδ T-cell responses by TLR ligands. Cell Mol Life Sci". 68:2357-70. doi: 10.1007/s00018-011-0699-1.
84. Yuasa T, Sato K, Ashihara E, Takeuchi M, Maita S, Tsuchiya N, et al.(2009). Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model. Cancer Immunol, Immunother58(4): 493-502. doi: 10.1007/s00262-008-0571-9.